Δευτέρα 27 Μαρτίου 2017

CHMP recommends nivolumab for the treatment of SCCHN

The Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of nivolumab as monotherapy for the treatment of squamous cell cancer of the head and neck (SCCHN) in adults progressing on or after platinum-based therapy. This CHMP...

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2nXDFac
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Δημοφιλείς αναρτήσεις